AMED - Amedisys, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
126.89
+0.39 (+0.31%)
At close: 4:00PM EST

127.68 +0.79 (0.63%)
After hours: 5:08PM EST

Stock chart is not supported by your current browser
Previous Close126.50
Open126.57
Bid126.78 x 1100
Ask144.25 x 800
Day's Range126.31 - 128.47
52 Week Range49.98 - 140.91
Volume370,704
Avg. Volume529,809
Market Cap4.046B
Beta (3Y Monthly)1.76
PE Ratio (TTM)49.22
EPS (TTM)2.58
Earnings DateFeb 25, 2019 - Mar 1, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est125.00
Trade prices are not sourced from all markets
  • Henry Schein Animal Health Spin-Off Approaches, Cost Mounts
    Zacks13 hours ago

    Henry Schein Animal Health Spin-Off Approaches, Cost Mounts

    Henry Schein's (HSIC) animal health spin-off will help it boost growth opportunities in dental space to deliver quality clinical care plus advanced wellness and prevention.

  • Why You Should Consider Buying Omnicell (OMCL) Stock Now
    Zacks2 days ago

    Why You Should Consider Buying Omnicell (OMCL) Stock Now

    Omnicell (OMCL) is pulling out all the stops to strengthen the medication adherence segment.

  • GlobeNewswire2 days ago

    HomeCare Elite Honors 166 Amedisys Home Health Care Centers

    Amedisys, Inc. (AMED), America’s leading independent home health, hospice and personal care company, today announced that 166 of its home health care centers were named to the 2018 HomeCare EliteTM, a recognition of the top-performing home health agencies in the United States. The 2018 recognition honored 51 percent of Amedisys’ home health agencies, marking the Company’s best showing in its history for these awards. “This result affirms that our strategy of achieving true clinical distinction in the industry is working and advancing our vision of becoming the nation’s premiere solution for aging in place,” stated Teonie Aurelio, President of Amedisys’ Home Health Division.

  • Markit3 days ago

    See what the IHS Markit Score report has to say about Amedisys Inc.

    # Amedisys Inc ### NASDAQ/NGS:AMED View full report here! ## Summary * Bearish sentiment is low ## Bearish sentiment Short interest | Positive Short interest is low for AMED with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ## Money flow ETF/Index ownership | Neutral ETF activity is neutral. The net inflows of $3.35 billion over the last one-month into ETFs that hold AMED are not among the highest of the last year and have been slowing. ## Economic sentiment PMI by IHS Markit | Neutral According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • QIAGEN QFT-Plus Ok'd in Canada, Test Customer Base Expands
    Zacks3 days ago

    QIAGEN QFT-Plus Ok'd in Canada, Test Customer Base Expands

    QIAGEN (QGEN) progresses with plans to widen customer base for QuantiFERON-TB Gold Plus test.

  • Is Amedisys (AMED) Stock Outpacing Its Medical Peers This Year?
    Zacks4 days ago

    Is Amedisys (AMED) Stock Outpacing Its Medical Peers This Year?

    Is (AMED) Outperforming Other Medical Stocks This Year?

  • Here's Why You Should Invest in Illumina (ILMN) Stock Now
    Zacks4 days ago

    Here's Why You Should Invest in Illumina (ILMN) Stock Now

    Illumina's (ILMN) product launches continue to contribute to the top line. The company's recent broadening of genotyping sequencing line buoys optimism.

  • Is Amedisys, Inc.’s (NASDAQ:AMED) CEO Pay Justified?
    Simply Wall St.8 days ago

    Is Amedisys, Inc.’s (NASDAQ:AMED) CEO Pay Justified?

    In 2014 Paul Kusserow was appointed CEO of Amedisys, Inc. (NASDAQ:AMED). First, this article will compare CEO compensation with compensation at similar sized companies. Then we'll look at a snap Read More...

  • Zacks.com featured expert Kevin Matras highlights: Amedisys, Foot Locker, Shoe Carnival, Tractor Supply and Caseys General Stores
    Zacks9 days ago

    Zacks.com featured expert Kevin Matras highlights: Amedisys, Foot Locker, Shoe Carnival, Tractor Supply and Caseys General Stores

    Zacks.com featured expert Kevin Matras highlights: Amedisys, Foot Locker, Shoe Carnival, Tractor Supply and Caseys General Stores

  • Markit9 days ago

    See what the IHS Markit Score report has to say about Amedisys Inc.

    # Amedisys Inc ### NASDAQ/NGS:AMED View full report here! ## Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low ## Bearish sentiment Short interest | Positive Short interest is low for AMED with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ## Money flow ETF/Index ownership | Positive ETF activity is positive. Over the last month, growth of ETFs holding AMED is favorable, with net inflows of $5.44 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing. ## Economic sentiment PMI by IHS Markit | Neutral According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Zacks.com featured expert Kevin Matras highlights: Helmerich & Payne, Manulife Financial, HEICO, Amedisys and Titan Machinery
    Zacks10 days ago

    Zacks.com featured expert Kevin Matras highlights: Helmerich & Payne, Manulife Financial, HEICO, Amedisys and Titan Machinery

    Zacks.com featured expert Kevin Matras highlights: Helmerich & Payne, Manulife Financial, HEICO, Amedisys and Titan Machinery

  • Zacks.com featured expert Kevin Matras highlights: BJ's Restaurants, O'Reilly Automotive, Amedisys, HCA Healthcare and Toyota Motor
    Zacks10 days ago

    Zacks.com featured expert Kevin Matras highlights: BJ's Restaurants, O'Reilly Automotive, Amedisys, HCA Healthcare and Toyota Motor

    Zacks.com featured expert Kevin Matras highlights: BJ's Restaurants, O'Reilly Automotive, Amedisys, HCA Healthcare and Toyota Motor

  • 5 Quality Stock Picks Based on DuPont Analysis
    Zacks10 days ago

    5 Quality Stock Picks Based on DuPont Analysis

    Bet on five top-ranked stocks with higher ROE derived from the DuPont way.

  • Buy These 5 Low Leverage Stocks to Stay Away From Debt Traps
    Zacks10 days ago

    Buy These 5 Low Leverage Stocks to Stay Away From Debt Traps

    Since debt-ridden companies are more vulnerable at times of crisis, it is better to avoid those. Of course, entirely avoiding companies with debt loads is virtually impossible.

  • Here Are 5 Stocks With Amazing Interest Coverage Ratio
    Zacks11 days ago

    Here Are 5 Stocks With Amazing Interest Coverage Ratio

    Interest Coverage Ratio is used to determine how effectively a company can pay the interest charged on its debt.

  • Here's Why You Should Add Amedisys (AMED) to Your Portfolio
    Zacks16 days ago

    Here's Why You Should Add Amedisys (AMED) to Your Portfolio

    Amedisys (AMED) is developing and acquiring new business lines that will complement its existing home care and hospice business.

  • Amedisys (AMED) Gains As Market Dips: What You Should Know
    Zacks20 days ago

    Amedisys (AMED) Gains As Market Dips: What You Should Know

    In the latest trading session, Amedisys (AMED) closed at $114.79, marking a +0.88% move from the previous day.

  • Is Amedisys (AMED) Stock Outpacing Its Medical Peers This Year?
    Zacks22 days ago

    Is Amedisys (AMED) Stock Outpacing Its Medical Peers This Year?

    Is (AMED) Outperforming Other Medical Stocks This Year?

  • The Zacks Analyst Blog Highlights: Computer Programs and Systems, BioTelemetry, HMS, Amedisys and Molina Healthcare
    Zacks22 days ago

    The Zacks Analyst Blog Highlights: Computer Programs and Systems, BioTelemetry, HMS, Amedisys and Molina Healthcare

    The Zacks Analyst Blog Highlights: Computer Programs and Systems, BioTelemetry, HMS, Amedisys and Molina Healthcare

  • 5 Great Healthcare Stocks to Buy for 2019
    Zacks23 days ago

    5 Great Healthcare Stocks to Buy for 2019

    Rapid innovation, major advances and an ageing population have managed to sustain the popularity of healthcare stocks.

  • 5 Nasdaq Composite Stocks That Braved the Index's Bloodbath
    Zacks23 days ago

    5 Nasdaq Composite Stocks That Braved the Index's Bloodbath

    Despite a plummeting Nasdaq Composite, a few companies have survived the turbulence because of their internal strengths.

  • Ring in 2019 With These 7 Solid Growth Stocks in Your Kitty
    Zacks25 days ago

    Ring in 2019 With These 7 Solid Growth Stocks in Your Kitty

    Let's take a look at seven growth stocks that are poised to offer impressive returns in 2019.

  • Zacks.com featured highlights include: Amedisys, Marine Products, Foot Locker, Systemax and Comfort Systems
    Zacks27 days ago

    Zacks.com featured highlights include: Amedisys, Marine Products, Foot Locker, Systemax and Comfort Systems

    Zacks.com featured highlights include: Amedisys, Marine Products, Foot Locker, Systemax and Comfort Systems

  • Ride on DuPont Analysis With 5 Top Stocks
    Zacks29 days ago

    Ride on DuPont Analysis With 5 Top Stocks

    Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.